Search results
Author(s):
Thomas Modine
Added:
9 months ago
EuroPCR25 - Findings from TRINITY trial show favourable outcomes with the LuX-Valve Plus TTVR system in high-risk patients with severe tricuspid regurgitation.We are joined by Prof Thomas Modine (CHU de Bordeaux, Bordeaux, FR) to discuss key findings from the TRINITY trial. This prospective, single-arm, multi-center study evaluated the LuX-Valve Plus transjugular tricuspid valve replacement…
View more
Aldosterone Synthase Inhibitors
Author(s):
Shubh K Patel
,
Hwee Teoh
,
Ahreni Saunthar
,
et al
Added:
6 months ago
Review Article
Conduction System Pacing: A Fresh Look
Author(s):
Óscar Cano, Marek Jastrzębski, Pugazhendhi Vijayaraman
Start date:
Nov 13, 2024
Broadcast
Isabel Liu
Author
Added:
7 months ago
Source:
Radcliffe Cardiology
With global temperatures rising and heatwaves becoming more frequent and intense, the impact on public health is a growing concern. A new scientific statement from the European Society of Cardiology (ESC) and several of its constituent bodies highlights the significant risk that extreme heat poses to cardiovascular health, particularly for the elderly and individuals with pre-existing…
View more
Author(s):
Deepak L Bhatt
Added:
11 months ago
In this insightful interview, Dr Deepak Bhatt (Mount Sinai Hospital, US) joins us to discuss findings from a post-hoc analysis of the REDUCE-IT trial, examining how icosapent ethyl affects cardiovascular outcomes across different baseline LDL-C levels.The study included 8,175 statin-treated patients with elevated cardiovascular risk and triglyceride levels between 135-499mg/dL. All participants…
View more
Edith Pituskin
Research Area(s) / Expertise:
Job title: Associate Professor
Author
Ewa Jankowska
Research Area(s) / Expertise:
Author
Author(s):
Mohammed El-Sheikh
,
Nora Olsen El Caidi
,
Aginsha Kandiah
,
et al
Added:
4 months ago
Author(s):
Michael Kiernan
Added:
1 year ago
HFA 24 - We are joined onsite by Dr Michael Kiernan (Tufts University School of Medicine, US) to discuss the findings from the PROACTIVE-HF Trial.PROACTIVE-HF is a prospective, multicenter, open-label single arm trial which aimed to assess the device safety and efficacy of the Cordella Pulmonary Artery Sensor System in a population of 529 New-York Heart Association (NYHA) class III heart failure…
View more
